Tom Drake

Dr Tom Drake serves as an Honorary Clinical Lecturer at the School of Cancer Sciences, University of Glasgow. His academic work focuses on cancer research with particular emphasis on liver cancer mechanisms, hepatocellular carcinoma, and clinical oncology applications.

Dr Drake's research interests span multiple domains within cancer biology. His work investigates liver regeneration processes, molecular mechanisms of hepatocellular carcinoma development, and innovative immunotherapy approaches for liver cancer treatment. He has contributed significantly to understanding the role of pericentral hepatocytes in liver regeneration and developed research on hepatic glutamine synthetase in cancer metabolism.

His publication record demonstrates a strong interdisciplinary approach combining basic science with clinical applications. Recent work shows progression from fundamental molecular biology studies to population-level clinical research on cancer surveillance programs. The publications reveal expertise in translational research that bridges laboratory discoveries with patient care improvements, particularly in liver cancer diagnostics and treatment.

Dr Drake has participated in significant collaborative research efforts including the ISARIC4C CCP-UK cohort study analyzing recovery patterns from severe Covid-19 illness. His work often involves multidisciplinary teams spanning basic science laboratories, clinical departments, and public health research units.